ALPN

Alpine Immune Sciences, Inc. ALPN

Trading inactive

ALPN
Alpine Immune Sciences, Inc. GBT
Global Blood Therapeutics, Inc. RYZB
RayzeBio, Inc. Common Stock MRTX
Mirati Therapeutics, Inc. CCXI
ChemoCentryx, Inc. CBAY
CymaBay Therapeutics, Inc. TPTX
Turning Point Therapeutics, Inc. SWTX
SpringWorks Therapeutics, Inc. ASPHF
Ascentage Pharma Group International ISEE
IVERIC bio, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode ALPN GBT RYZB MRTX CCXI CBAY TPTX SWTX ASPHF ISEE
6M 243.76 % 2.61 % 218.50 % 55.04 % 2.50 % 138.65 % 0.12 % 25.31 % 60.14 % 88.98 %
YTD 241.95 % 0.00 % 0.87 % -0.69 % 0.00 % 36.99 % 0.00 % 30.24 % 246.47 % 98.56 %
1Y 475.98 % 124.93 % 160.38 % 29.44 % 71.87 % 215.95 % 125.75 % 30.85 % 246.47 % 198.58 %
3Y 635.79 % -8.64 % 160.38 % -70.69 % 5.54 % 678.90 % 14.08 % 67.46 % 52.79 % 781.90 %
5Y 1 343.78 % 14.25 % 160.38 % -22.29 % 479.60 % 169.54 % 161.21 % 10.23 % 52.79 % 1 504.42 %
10Y 8.86 % 58.87 % 160.38 % 171.51 % 348.58 % 364.00 % 161.21 % 107.64 % 52.79 % 51.90 %
From the beginning 8.86 % 58.87 % 160.38 % 732.62 % 372.64 % 260.89 % 161.21 % 107.64 % 52.79 % 51.90 %

Dividend